A detailed history of Walleye Trading LLC transactions in Repligen Corp stock. As of the latest transaction made, Walleye Trading LLC holds 3,869 shares of RGEN stock, worth $553,460. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,869
Previous 25,600 84.89%
Holding current value
$553,460
Previous $3.23 Million 82.18%
% of portfolio
0.0%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$119.79 - $167.35 $488,383 - $682,285
-4,077 Reduced 51.31%
3,869 $575,000
Q2 2024

Aug 14, 2024

BUY
$120.0 - $182.95 $953,520 - $1.45 Million
7,946 New
7,946 $1 Million
Q4 2023

Feb 14, 2024

BUY
$114.17 - $185.35 $587,404 - $953,625
5,145 Added 99.15%
10,334 $1.86 Million
Q3 2023

Nov 14, 2023

SELL
$138.78 - $176.51 $504,326 - $641,437
-3,634 Reduced 41.19%
5,189 $825,000
Q2 2023

Aug 14, 2023

BUY
$138.42 - $180.31 $1.22 Million - $1.59 Million
8,823 New
8,823 $1.25 Million
Q2 2021

Aug 16, 2021

BUY
$165.87 - $220.95 $344,014 - $458,250
2,074 Added 188.89%
3,172 $633,000
Q4 2020

Feb 16, 2021

BUY
$148.08 - $206.57 $111,208 - $155,134
751 Added 216.43%
1,098 $210,000
Q3 2020

Nov 16, 2020

BUY
$122.51 - $158.27 $42,510 - $54,919
347 New
347 $51,000
Q1 2020

May 15, 2020

SELL
$84.96 - $109.14 $101,442 - $130,313
-1,194 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$73.84 - $93.08 $65,274 - $82,282
-884 Reduced 42.54%
1,194 $110,000
Q1 2019

May 15, 2019

SELL
$49.45 - $62.8 $166,745 - $211,761
-3,372 Reduced 61.87%
2,078 $123,000
Q4 2018

Feb 14, 2019

BUY
$48.26 - $68.88 $124,800 - $178,123
2,586 Added 90.29%
5,450 $287,000
Q3 2018

Nov 14, 2018

BUY
$46.8 - $58.97 $134,035 - $168,890
2,864 New
2,864 $159,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7.94B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.